论文部分内容阅读
目的：评价内镜下三联疗法治疗进展期食管贲门胃底癌疗效。方法：采用内镜下三联疗法（包括激光光动力学疗法、微波和局部注射化疗药物）。根据癌肿的类型、病变范围的不同有区别地采用内镜下三联疗法进行治疗。结果：采用内镜下三联疗法共治疗５３例病人，并对其中３３例进行了随访，近期疗效为：ＣＲ２５例，ＰＲ８例，无无效者。通过１５个月随访，３个月生存率为８４８４％，６个月生存率为６０６１％（其中包括６例仍存活，随访时间达６—１０个月）。全部病人均未发生毒性反应和并发症。结论：从近期疗效及１５个月随访看出内镜下三联疗法是一种科学、有效、安全的方法
OBJECTIVE: To evaluate the efficacy of endoscopic triple therapy in the treatment of advanced esophageal gastric cardia cancer. METHODS: Endoscopic triple therapy (including laser photodynamic therapy, microwave and local injection chemotherapy drugs) was used. According to the type of cancer and the extent of the lesion, endoscopic triple therapy is used differently. RESULTS: A total of 53 patients were treated with endoscopic triple therapy and 33 of them were followed up. The short-term efficacy was: CR 25 cases, PR 8 cases, and no effect. After 15 months of follow-up, the 3-month survival rate was 84.4%, and the 6-month survival rate was 60. 61% (including 6 cases that were still alive and follow-up for 6-10 months). No toxicity or complications occurred in all patients. Conclusion: From the short-term efficacy and 15-month follow-up, endoscopic triple therapy is a scientific, effective and safe method.